HSDD is estimated to affect about 10% of women in the United States, according to a 2022 review in CNS Spectrums , and Vyleesi is one of only two FDA-approved therapies specifically indicated for female sexual desire
This includes inflammatory markers, nutrient levels, hormone panels, and metabolic indicators
This reduces allergic mediators such as histamine and alleviates allergic reactions
Balanced diets coupled with exercises are the first line of intervention to help curb the development of varicosity and relieve the symptoms
improve your overall lifestyle and diet choices, injections likely wont do much to improve overall quality of life
Concern and Recommendations: Medically, the major concern right now with BPC 157 is a lack of evidence confirming safety in humans